Is there continued evidence for an association between abacavir usage and myocardial infarction risk in individuals with HIV? A cohort collaboration.
about
Cardiovascular Complications of HIV Infection.Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patientsHIV infection as vascular risk: A systematic review of the literature and meta-analysis.Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA PanelAging, Health, and Quality of Life for Older People Living With HIV in Sub-Saharan Africa: A Review and Proposed Conceptual Framework.Epidemiology of ischemic heart disease in HIV.Telmisartan increases vascular reparative capacity in older HIV-infected adults: a pilot study.Nucleoside reverse transcriptase inhibitor-reducing strategies in HIV treatment: assessing the evidence.The changing face of an epidemic: healthy old age with HIV.Moving forward with treatment options for HIV-infected children.Antiviral Activity, Safety, and Pharmacokinetics of Bictegravir as 10-Day Monotherapy in HIV-1-Infected Adults.HIV viral kinetics and T cell dynamics in antiretroviral naïve persons starting an integrase strand transfer inhibitor and protease inhibitor regimen.Risk of cardiovascular events from current, recent, and cumulative exposure to abacavir among persons living with HIV who were receiving antiretroviral therapy in the United States: a cohort study.Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-week results of a randomized trial.Recent abacavir use increases risk for Types 1 and 2 myocardial infarctions among adults with HIV.Management of Long-Term Complications of HIV Disease: Focus on Cardiovascular Disease.A Review of Long-Term Toxicity of Antiretroviral Treatment Regimens and Implications for an Aging Population.Abacavir Use and Risk for Myocardial Infarction and Cardiovascular Events: Pooled Analysis of Data From Clinical Trials.
P2860
Q30235920-006ECA8A-9090-44BE-A96E-D46475A14C5CQ36278470-189BC5BE-EC6D-4AC5-AEE4-665A01BE57D2Q36368959-0FA39ACB-D935-4EE5-9017-7E389B1C43ECQ37234729-414B70A4-7360-4DA6-938D-8A89476D723DQ38368637-019AF0E7-8207-420E-997E-9E65F187571FQ38629009-0D598F68-254E-42D9-ABDD-ACFFDFB7EFD1Q39361501-C526464B-D8C7-4890-97A9-9588C5646F32Q39453985-73482D74-B466-4202-AD84-686F36ADF9C6Q40045681-EE631FCD-0C6E-43B5-81C6-DB5E33A39637Q40063042-322A1853-CE34-4081-B630-D6E3520D4C06Q40333725-4328E31A-0B8B-4B0C-9E43-428B28EB6234Q40353844-4157055B-86DE-4D11-94DD-868FA688DFE2Q42609996-3460B44F-4298-481C-A43A-9B060EE8CCECQ45170011-795F4685-5046-4329-BF0C-69D643044B1CQ50054016-63FDE39B-15BA-4768-BF49-EC1BEE118543Q52566637-C54D112B-AFBA-4EE7-A02B-97C0E4D8C0EDQ54211761-ADCD03D0-A941-43AB-A4D7-37B026DF40F1Q55001110-073D02FF-4027-47F5-A4C7-CD9A10711B11
P2860
Is there continued evidence for an association between abacavir usage and myocardial infarction risk in individuals with HIV? A cohort collaboration.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Is there continued evidence fo ...... h HIV? A cohort collaboration.
@ast
Is there continued evidence fo ...... h HIV? A cohort collaboration.
@en
type
label
Is there continued evidence fo ...... h HIV? A cohort collaboration.
@ast
Is there continued evidence fo ...... h HIV? A cohort collaboration.
@en
prefLabel
Is there continued evidence fo ...... h HIV? A cohort collaboration.
@ast
Is there continued evidence fo ...... h HIV? A cohort collaboration.
@en
P2093
P2860
P50
P1433
P1476
Is there continued evidence fo ...... h HIV? A cohort collaboration.
@en
P2093
Andrew N Phillips
Colette Smith
D:A:D Study Group
Eric Fontas
Peter Reiss
Rainer Weber
Stephane de Wit
P2860
P2888
P356
10.1186/S12916-016-0588-4
P407
P50
P577
2016-03-31T00:00:00Z
P6179
1035981253